Hookipa Pharma

New York, United States

Hookipa is a clinical stage biotech company developing best-in-class active immunization therapies for infectious diseases and oncology.

Dec 2023

Post-IPO Equity

Biotechnology Clinical Trials Oncology Therapeutics

Top Investors

Hillhouse InvestmentGilead SciencesSamsara BioCapitalRedmile GroupSofinnova Partners

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Hookipa Pharma

Who are Hookipa Pharma's investors?

Hookipa Pharma's investors include Hillhouse Investment, Gilead Sciences, Samsara BioCapital, Redmile Group, Sofinnova Partners.

Where is Hookipa Pharma headquartered?

Hookipa Pharma is headquartered in New York, United States.

What does Hookipa Pharma do?

Hookipa is a clinical stage biotech company developing best-in-class active immunization therapies for infectious diseases and oncology.

What stage is Hookipa Pharma at?

Hookipa Pharma is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated December 21, 2023.

MLA

"Hookipa Pharma — Funding & Investors." VCBacked, December 21, 2023, https://www.vcbacked.co/company/hookipa-pharma. Accessed July 1, 2026.

APA

VCBacked. (2023). Hookipa Pharma — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/hookipa-pharma

Wikipedia (cite web)

{{cite web |title=Hookipa Pharma — Funding & Investors |url=https://www.vcbacked.co/company/hookipa-pharma |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated December 21, 2023.

Similar Companies in Biotechnology

View all

Renaissance BioScience

Vancouver

Rapport Therapeutics

Boston

Neuroglee Therapeutics

Singapore

Living In Silico Inc.